Combretastatin A4/poly(L-glutamic acid)-graft-PEG conjugates self-assembled to nanoparticles

Combretastatin A4 (CA4) possesses varying ability to cause vascular disruption in tumors, while the short half-life, low water solubility and deactivation of many CA4 analogs during storage limited its antitumor efficacy and drug stability. A novel macromolecular conjugate of CA4 (CA4-PL) was synthe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Yang, Tang, Zhao-hui, Sun, Lu, Yu, Hai-yang, Li, Jia, Zhao, Mei-hui, Xu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2018
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032092/
https://www.ncbi.nlm.nih.gov/pubmed/32104392
http://dx.doi.org/10.1016/j.ajps.2017.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032092/
https://www.ncbi.nlm.nih.gov/pubmed/32104392
http://dx.doi.org/10.1016/j.ajps.2017.10.001

Ejemplares similares